hydrazine has been researched along with Osteogenic Sarcoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z; Su, Q; Tian, Z; Xu, B | 1 |
| Erickson, SW; Gatto, G; Gill, J; Gorlick, R; Kolb, EA; Nevil, G; Roth, M; Smith, M; Teicher, B; Zhang, W | 1 |
| Argenziano, M; Di Martino, M; Di Paola, A; Di Pinto, D; Perrotta, S; Pota, E; Punzo, F; Rossi, F; Tortora, C | 1 |
| Breitbach, JT; Davies, AE; Fenger, JM; Louke, DS; Tobin, SJ; Watts, MR | 1 |
| Depping, R; Dunst, J; Kosyna, FK; Landesman, Y; Mandl, M; von Fallois, M | 1 |
| Arnold, MA; Bid, HK; Brandolini, L; Cam, H; Cam, M; Gross, AC; Hinckley, JM; Houghton, PJ; London, CA; Mo, X; Phelps, DA; Roberts, RD; Saraf, AJ; Winget, SA | 1 |
| Dai, EN; Li, JM; Liu, B; Tian, JX; Xu, L | 1 |
| Liu, W; Ma, N; Niu, JC; Wang, PJ | 1 |
| Aboukameel, A; Argueta, C; Azmi, AS; Drolen, C; Kashyap, T; Kauffman, M; Klebanov, B; Landesman, Y; Lee, M; Mohammad, RM; Muqbil, I; Senapedis, W; Shacham, S; Unger, TJ | 1 |
| Bartek, J; Bekker-Jensen, S; Falck, J; Goldberg, M; Jackson, SP; Lerenthal, Y; Lukas, C; Lukas, J; Melander, F; Stucki, M | 1 |
| Kimura, A; Lawson, D; Lee-Ambrose, L; Mehta, P; Ward, MB | 1 |
11 other study(ies) available for hydrazine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Novel 1,3,5-triazine-nicotinohydrazide derivatives induce cell arrest and apoptosis in osteosarcoma cancer cells and inhibit osteosarcoma in a patient-derived orthotopic xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Female; Humans; Hydrazines; Mice; Mice, Nude; Nicotine; Osteosarcoma; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Triazines; Xenograft Model Antitumor Assays | 2022 |
Initial
Topics: Animals; Bacterial Outer Membrane Proteins; Benzoates; Disease Models, Animal; Escherichia coli Proteins; Female; Humans; Hydrazines; Male; Mice; Multienzyme Complexes; Osteosarcoma; Pyrazoles; Xenograft Model Antitumor Assays | 2021 |
Effects of Iron Chelation in Osteosarcoma.
Topics: Apoptosis; Benzoates; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferasirox; Drug Therapy, Combination; Humans; Hydrazines; Iron Chelating Agents; Osteosarcoma; Pyrazoles; Treatment Outcome | 2021 |
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Biological Products; Cell Line, Tumor; Dog Diseases; Dogs; Doxorubicin; Hydrazines; Osteosarcoma | 2021 |
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity.
Topics: Apoptosis; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hypoxia-Inducible Factor 1, alpha Subunit; Karyopherins; Liver Neoplasms; Osteosarcoma; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Cells, Cultured | 2021 |
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Cytokine Receptor gp130; Drug Evaluation, Preclinical; Follow-Up Studies; Humans; Hydrazines; Interleukin-6; Interleukin-8; Lung; Lung Neoplasms; Male; Mice; Osteosarcoma; Primary Cell Culture; Quinoxalines; Receptors, Interleukin-8A; Sulfonamides; Xenograft Model Antitumor Assays; Young Adult | 2018 |
Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Hydrazines; Indoles; Osteosarcoma; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dinoprostone; Gene Silencing; Humans; Hydrazines; Mice; Mice, Nude; Osteosarcoma; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Xenograft Model Antitumor Assays | 2019 |
Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bortezomib; Cell Death; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Female; Fibrosarcoma; Humans; Hydrazines; Karyopherins; Mice, Inbred ICR; Mice, SCID; NF-kappa B; NF-KappaB Inhibitor alpha; Osteosarcoma; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Receptors, Cytoplasmic and Nuclear; RNA Interference; Signal Transduction; Time Factors; Transcription Factor RelA; Transfection; Triazoles | 2016 |
Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention.
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Chromatin; DNA Damage; DNA-Binding Proteins; Fluorescent Antibody Technique; Fluorescent Dyes; Histones; Humans; Hydrazines; Microscopy, Confocal; Nuclear Proteins; Osteosarcoma; Phosphoproteins; Protein Structure, Tertiary; RNA Interference; RNA, Small Interfering; Trans-Activators | 2004 |
Effects of thromboxane A2 inhibition on osteogenic sarcoma cell-induced platelet aggregation.
Topics: Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Fatty Acids, Unsaturated; Humans; Hydrazines; Methacrylates; Osteosarcoma; Platelet Aggregation; Thromboxane A2 | 1986 |